Evidence map›Paper›PMID 24924800›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

A role beyond learning for NMDA receptors in reward-based decision-making-a pharmacological study using d-cycloserine.

Jacqueline Scholl, Jan Günthner, Nils Kolling, Elisa Favaron, Matthew Fs Rushworth, Catherine J Harmer, Andrea Reinecke

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Trial
  4. Trial
  5. Trial
  6. The NMDA receptor partial agonist d-cycloserine does not enhance motor learning.Journal of psychopharmacology (Oxford, England) · 2016
    Trial
  7. Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The Good, the Bad, and the Irrelevant: Neural Mechanisms of Learning Real and Hypothetical Rewards and Effort.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jacqueline SchollDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Jan GünthnerDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Nils KollingDepartment of Experimental Psychology, University of Oxford, Oxford, UK.
Elisa FavaronDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Matthew Fs Rushworth1] Department of Experimental Psychology, University of Oxford, Oxford, UK [2] Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB), University of Oxford, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Catherine J HarmerDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Andrea ReineckeDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
Warneford Hospital · GBUniversity of Oxford · GB

Funding

Medical Research Council G0902373Medical Research Council MR/J011878/1Wellcome Trust 089280Wellcome Trust 089280/Z/09/ZWellcome Trust 092759/Z/10/ZWellcome Trust 100973Wellcome Trust WT100973AIA
6 · The paper itself

Abstract

N-methyl-D-aspartate (NMDA) receptors are known to fulfill crucial functions in many forms of learning and plasticity. More recently, biophysical models, however, have suggested an additional role of NMDA receptors in evidence integration for decision-making, going beyond their role in learning. We designed a task to study the role of NMDA receptors in human reward-guided learning and decision-making. Human participants were assigned to receive either 250 mg of the partial NMDA agonist d-cycloserine (n=20) or matching placebo capsules (n=27). Reward-guided learning and decision-making were assessed using a task in which participants had to integrate learnt and explicitly shown value information to maximize their monetary wins and minimize their losses. To tease apart the effects of NMDA on learning and decision-making we used simple learning models. D-cycloserine shifted decision-making towards a more optimal integration of the learnt and the explicitly shown information, in the absence of a direct learning effect. In conclusion, our results reveal a distinct role for NMDA receptors in reward-guided decision-making. We discuss these findings in the context of NMDA's roles in neuronal super-additivity and as crucial for evidence integration for decisions.

Indexed as

RewardAdolescentAdultAntimetabolitesCycloserineDecision MakingDouble-Blind MethodFemaleHumansLearningLogistic ModelsMaleNeuropsychological TestsReceptors, N-Methyl-D-AspartateSurveys and QuestionnairesYoung AdultAntimetabolitesCycloserineReceptors, N-Methyl-D-Aspartate

Identifiers

PMID24924800
PMCPMC4200501
OpenAlexW2028514086

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.